1. Anterior tibial muscle protein synthesis in seven healthy postabsorptive men was determined from increases in muscle protein bound leucine enrichment during a primed continuous infusion of L-[ l-13C]leucine. Biopsies were taken 30 min after the beginning of leucine infusion (when plasma 13C enrichment was steady), 240 min later during continued fasting and again after 240 min of infusion of a mixed amino acid solution which increased plasma total amino acid concentrations by 37%. The mean enrichment of 13C in plasma a-ketoisocaproate was used as an index of the enrichment of the precursor pool for leucine metabolism.
INTRODUCTION
Studies of quadriceps muscle protein synthetic rates in man have shown increases during mixed oral feeding [l, 21, and studies in a variety of disease states [2-41 and during leg immobilization [5] have shown reductions from normal in muscle protein synthesis, but the mechanisms remain obscure.
In model-dependent studies of amino acid exchange across human limbs, an apparent increase in protein synthesis but no change in protein breakdown occurred during mixed oral feeding which should elevate insulin secretion [6, 7] , but, paradoxically, insulin infusion in fasting subjects not only did not induce an increase in indirect indices of protein synthesis but reduced protein breakdown [8] .
The individual contributions of amino acids, energy (i.e. equivalents of carbohydrate and lipids) and other paracrine and endocrine hormones in the control of skeletal muscle protein synthesis in man are not known. It is known that in man, infusion of substantial amounts of either leucine [9] or mixed amino acids [ 10, 111 increased whole-body protein synthesis but only a mixed amino acid infusion reduced whole-body protein breakdown, and although the branched-chain amino acids and leucine in particular are said to have anabolic effects on animal muscle no data exist for human muscle. We have begun to tackle these problems by examining the effect of amino acid supply on skeletal muscle protein synthesis.
The aim of the study reported here was to apply stable isotope tracer technology to study the effects on the skeletal muscle protein synthetic rate in postabsorptive man of an intravenous infusion of mixed amino acids without additional fuel substrates or hormones. A subsidiary aim was to assess the contribution of skeletal muscle to whole-body protein turnover and to examine the changes induced by provision of amino acids.
METHODS

Subjects
Seven healthy men [age 24.5-39.5 years; weight 67.8-77.4 kg (101-114% ideal body weight [12, 13] )] were studied at the Department of Medicine, Ninewells Hospital and Medical School, University of Dundee. Each subject gave written consent after a full explanation of the study. The study protocol was approved by the Tayside Health Board Committee on Medical Ethics. 
Experimental design
The subjects were studied after a 15 h overnight fast; they received no food throughout the study, during which they were semi-recumbent in a thermoneutral environment (25-27°C). Arterialized venous blood samples were taken from a 1.7 mm outer diameter cannula (Venflon, Viggo AB, Helsingborg, Sweden), placed retrogradely in a dorsal hand vein and maintained patent by slow infusion of NaCl solution (150 mmol/l); before sampling the hand was warmed by insertion into a thermostatic chamber at 75°C [14] . Priming 0.24) pmol h-' kg-'1 was established, via a 1.7 mm outer diameter cannula in a contralateral forearm vein; infusions were delivered and controlled with IMED 928 volumetric infusion pumps (IMED Ltd, Abington, Oxon, U.K.). Thirty minutes later (elapsed time 0 min) anterior tibial muscle was biopsied using 6.5 mm Tilley Henckel ethmoid punches (S. Murray and Co, Sheffield, U.K.) via a 10 mm long skin incision made using 5 ml of 20 g/1 lignocaine anaesthesia, subcutaneously infiltrated to the fascia [ 151. The biopsies were from the most muscular aspect of the skin at a depth of 10 mm below the fascia. Samples were immediately frozen in liquid nitrogen and stored at -194°C until analysis. A second biopsy was taken 240 min later (elapsed time 240 rnin), from either the ipsilateral leg (40 mm distant from the initial biopsy site) or the contralateral leg. A third anterior tibial biopsy was taken 240 rnin after the second biopsy (elasped time 480 min), from the leg contralateral to the first biopsy. After the second biopsy was taken a priming dose of a commercial preparation of mixed amino acids (Synthamin 9, Travenol Laboratories Ltd, Thetford, Norfolk, U.K.) was infused intravenously (83.5 mg of amino acids/kg over 10 rnin), with a second bolus of NaHl3C0, [0.94 (SD 0.03) pmol/kg]; amino acids were then continuously infused until the end of the study at a rate of 1.52 ml h-' kg-I providing 83.5 mg of amino acids h-' kg-l, 46 .5 pmol of leucine h-' kg-l and 0.33 g of nitrogen day-' kg-I. Each litre of Synthamin 9 contained the following L-amino acids: alanine 11.38 g, arginine 6.32 g, glycine 5.66 g, histidine 2.64 g, isoleucine 3.30 g, leucine 4.02 g, lysine 3.19 g, methionine 2.20 g, phenylalanine 3.08 g, proline 3.74 g, serine 2.75 g, threonine 3.21 g, tryptophan 0.99 g, tyrosine 0.22 g, valine 3.19 g, total amino acids 55.0 g.
Arterialized venous samples were taken before, 30 rnin after the start of the tracer infusion (time 0) and every 60 min thereafter for 480 min. Every 60 min, total CO, production, total 0, consumption and resting energy expenditure were determined over 11 min with a ventilated hood, indirect calorimeter [16] . Every 60 rnin expired breath was collected into a 2 litre plastic bag and an aliquot was transferred into 20 ml evacuated glass tubes (Vacutainer, Becton Dickenson, Rutherford, NJ, U.S.A.) for subsequent determination of I3C enrichment in CO, (see below).
I3C analysis
Enrichment with 13C in leucine in plasma and neutralized perchloric acid extracts of freeze-dried, ground muscle were determined after the procedure described below. Urea, which otherwise interfered with gas chromatography-mass spectrometry, was removed by incubation (37"C, 15 min) with jack-bean urease; amino acids were extracted (plasma samples only) with methanolic HCl(4: 1, v/v), the solvent removed by evaporation, and then the residue redissolved in pyridine before preparation of t-butyldiemethylsilyl derivatives by reaction with N-methyl-N-(t-butyldimethylsilyl)trifluoroacetamide (Regis Chemical Company, Morton Grove, IL, U.S.A.) [ 171. Gas chromatography-mass spectrometry was carried out on a Finnigan 1020B instrument (Finnigan MAT Ltd, Heme1 Hempstead, U.K.), fitted with a 20 m xO.2 mm inner diameter OV-1 WCOT chemically bonded fused silica column (Pierce UK Ltd, Cambridge, U.K.), with temperature programmed from 110 to 270°C at 15"C/min after a 1 rnin lag. Decane was used as solvent. The injector temperature was 280°C and injection, in the splitless mode, was complete in 30 s. The carrier gas was helium at 50 kPa. The mass spectrometer was operated in the electron impact mode with an ionization energy of 70 eV. [ l-'3C]Leucine enrichment was determined by monitoring m/z 302 and 303. The enrichment in a-ketoisocaproate (KIC) was determined by analogous methods using o-trimethylsilyl quinoxalinol derivates [ 181 and monitoring mlz 232 and 233.
Enrichment of I3C in expired CO, was measured with an automated Finnigan MAT breath gas analysis system attached to a Finnigan MAT Delta D isotope ratio mass spectrometer [ 191. To determine the I3C enrichment in protein-bound leucine, protein from freeze-dried, ground muscle samples was repeatedly washed with perchloric acid, acid-hydrolysed (6 mol/l HCl) and leucine was separated by preparative gas chromatography [20] . Leucine-CO, was liberated by ninhydrin and its 13C enrichment determined using the breath gas system optimized for small quantities of CO, [21] .
Metabolite and hormone concentration assays
Amino acid concentrations were determined h plasma and muscle sulphosalicylic acid or perchloric acid extracts with an amino acid analyser (LC5000, Biotronik GmbH, Munchen, F.D.R.) using ion-exchange chromatography and fluorimetric detection of o-phthaldehyde derivatives with norvaline as internal standard. Intracellular free amino acids were extracted from freeze-dried, ground muscle samples with 0.5 mol/l perchloric acid; calculation of the values for intracellular concentration and enrichment was made on the assumption that 13% of the water content, by weight, of the muscle sample was extracellular [22] . Concentrations of plasma glucose were determined with a Glucose Analyser 2 (Beckman Instruments, Irvine,
CA, U.S.A.) and of blood D-( -)-3-hydroxybutyrate by an
nicotinamide-adenine dinucleotide-linked enzyme assay [23] . Plasma hormone concentrations were measured at 180,240,420 and 480 min by radioimmunoassay, insulin by a double-antibody kit (Ire-Medgenix Sa, Brussels, Belgium), glucagon by a double-antibody kit (Radioassay Systems Laboratories Inc., Carson, CA, U.S.A.) and cortisol by a solid-phase primary antibody kit (Immunodiagnostic Systems Ltd, Washington, U.K.).
Calculations
Muscle protein synthetic rates were calculated from the increase in incorporation of L-[ l-13C]leucine into the protein-bound leucine pool, assuming that the mean 13C enrichment in plasma KIC from 0 to 240 min and 300 to 480 min reflected that in the precursor pool, in the absence and in the presence of amino acid infusion, respectively [ 1 ] . The components of plasma leucine turnover were calculated from the mean plasma KIC enrichment from 60 to 240 min and 300 to 480 min [l] . Leucine oxidation was calculated from whole-body 13C0, excretion and plasma KIC enrichment [l] ; during an additional study without tracer 13C, enrichment in expired CO, was only 0.00018 (SD 0.00015) atom per cent excess (APE) during amino acid infusion.
Statistical analysis
Mean values and their SD are presented. Results from the two phases of the study were compared with the Student's t-test for paired data.
RESULTS
Indirect calorimetry
Resting energy expenditure was 5.42 (SD 0.28) kJ/min in the absence of the amino acid infusion and increased to 5.87 (SD 0.27) ld/min (P<O.Ol) during the infusion. No change was found in the respiratory quotient (0.73 overall).
Substrates and hormones (Table 1) Values of the concentrations of plasma glucose, insulin, glucagon and cortisol and of blood D-( -)-3-hydroxybutyrate were stable within each study period, without and with amino acid infusion. During amino acid infusion insulin was 53% greater (P<0.05) and glucagon 41% greater (P< 0.01) compared with postabsorptive concentrations. Concentrations of glucose, D-( -)-3-hydroxybutyrate and cortisol were not affected by the amino acid infusion.
Amino acid concentrations ( Fig. 1 and Table 2) The mean plasma leucine concentration (Fig. 1 ) in the absence of amino acid infusion, from 0 to 240 min, was 157 (SD 22) pmol/l; a rise (P<0.05) of 16% occurred from 60 to 240 min. During amino acid infusion leucine increased by nearly 80% to a plateau value of 278 (SD 46) pmol/l (P<O.OOl) between 300 and 480 min. During fasting the concentration of free leucine in intramuscular fluid was not different from that in plasma at 167 (SD 22) pmol/l; this increased by 52% to 254 (SD 55) pmolll (P< 0.02) during amino acid infusion when there was no statistical difference between plasma and intramuscular free leucine concentrations. Total plasma amino acid concentration was 2890 (SD 260) pmol/l initially and a rise (P<O.OOl) of 37% to 3950 (SD 370) pmol/l occurred during amino acid infusion. During infusion no change was found in the plasma concentrations of aspartic acid and glutamine; reductions occurred in glutamic acid and taurine, amino acids not present in the mixture infused.
Plasma and muscle free leucine pool enrichments
For both plasma leucine and KIC, plateau enrichment was achieved during the last 180 min of each phase of the study (Fig. 1, Table 3 ). The ratio of I3C enrichment in plasma KIC relative to that in plasma leucine was 83 (SD 4) O/ O in the absence of exogenous amino acids and this was maintained [85 (SD 7) "/o] during amino acid infusion. The I3C enrichment in muscle free leucine was 4.26 (SD 1.56) APE 30 min after the ['3C]leucine bolus (time 0 min) and was 3.45 (SD 1.10) APE at the end of the first phase of the study before infusion of amino acids. This enrichment was unchanged [3.41 (SD 0.81) APE] during amino acid infusion despite reductions in the enrichment of I3C in both plasma leucine and plasma KIC (Table 3 ). The I3C enrichment of intramuscular free leucine was 5 1 rate]. Du&g amino acid. infusion, the rate of muscle protein synthesis calculated in this fashion [0.107 (SD 0.044) %/h] showed no significant difference from that calculated in the absence of exogenous amino acids.
Whole-body leucine kinetics (Table 5)
During the infusion a rise (P<O.OOl) of 26% occurred in the plasma leucine flux, but this increase was less than the exogenous leucine infusion rate because of a reduction (P<O.Ol) of 12% in the rate of appearance of endogenous leucine, a measure of protein breakdown. Whole-body leucine oxidation increased ( P < O.OOl), in absolute terms, to almost double the postabsorptive value during amino acid infusion; as a proportion of plasma leucine flux leucine oxidation rose from 15% to 22%. The non-oxidative rate of leucine disappearance, i.e. wholebody protein synthesis, increased (P<O.OOl) by 13% during the amino acid infusion. Net leucine uptake changed ( P < 0.001) from negative to positive, suggesting that net protein balance had become positive.
DISCUSSION
This study shows, for the first time, the effects of parenteral infusion of mixed amino acids on anterior tibial muscle protein synthesis. Information is also provided about the relationships of leucine and KIC in the (44) 101 (23) 82 (38) 673 (44) 237 (33) 92 (11) 157 (22) 181 (49) 54 (10) 124 (14) 71 (13) 128 (18) 8 (4) 55 (7) 19 (2) 44 (8) 47 (7) 254 (48) 2890 (260) - In essence, the results show that increases in amino acid availability in plasma and muscle stimulate muscle protein synthesis, calculated on the basis of the enrichments of plasma KIC or leucine, but not when calculated on the basis of intracellular leucine enrichment. The correct interpretation of these results depends on knowledge of the relative tracer labelling of muscle leucine tRNA, plasma leucine, intramuscular free leucine and the keto-acid of leucine, information not available for man. In previous studies of human muscle protein synthesis [l-51 + 12 (6)** we used the plasma leucine or KIC enrichments as the basis of our calculations, since six studies [24-291 of precursor pool labelling of leucine in skeletal and cardiac muscle, both in vitro and in vivo, showed tRNA labelling to be nearer to that of the extracellular, than to that of the intracellular, amino acid p c d , but one other study reports the opposite result [30] . The substantial transamination of leucine in human forearm arteriovenous exchange studies [6, 71 provides further evidence of rapid entry of extracellular leucine to intracellular metabolic processes.
(14)
The relative increase in the equilibrium between the intramuscular free leucine enrichment and that of plasma leucine during amino acid infusion is partly a function of the reduced arteriovenous decrement in leucine enrichment that occurs when plasma leucine concentrati0.n is increased [6, 7, 311 and partly to the increased flux of leucine [6, 71 in the fed state. The initial (time 0 min) higher intracellular leucine enrichment may have been a transient effect due to the bolus of [l-'3C]leucine or to an increase in protein breakdown during the initial period of the study. It remains a possibility that the lack of a significant effect of amino acid infusion on muscle protein synthesis, calculated on the basis of the free muscle leucine labelling, was a type 2 error: this may have occurred as a result of taking an insufficiently long period over which to measure the enrichment of muscle protein, or to the effect of the relative methodological precision of measurements made on small samples of free and proteinbound intramuscular leucine with a resulting greater variability of the calculated protein synthetic rates. Until information is available on the leucyl-tRNA charging of human skeletal muscle, rates of muscle protein synthesis derived from plasma KIC enrichment should be viewed as the best available estimates, rates derived from plasma leucine enrichment as minimal estimates and rates derived from intracellular leucine enrichment as overestimates.
Complete mixtures of amino acids are reported to enhance protein synthesis in cell-free systems, suggesting that there is a direct stimulatory effect of amino acids on protein synthesis [32] . There is, however, no known mechanism for this effect and the K , for the charging of tRNA is likely to be much lower than the intramuscular concentration of amino acids so that tRNA is always fully saturated [32] . Leucine has been reported to stimulate rat muscle protein synthesis in vitro [33] and whole-body protein synthesis in man [9] , but this may occur by indirect and unknown mechanisms. Branched-chain amino acids have no effect on muscle amino acid balance [34] or ribosome profile in man [35] . However, our results showed that amino acid infusion caused an increase in intramuscular leucine and other branched-chain amino acid concentrations so that if they were anabolic there was scope for the effect to be expressed.
To what extent are the increases in muscle protein synthesis likely to result from the small increases in insulin? Many studies in animals both in vitro [29, 36, 371 and in vivo [38, 391 provide evidence of a stimulatory effect of insulin on muscle protein synthesis, most sensitive in the range 0-15 m-units/l [40] . Studies in adult man conflict with these animal-based results, suggesting that insulin may not have an anabolic effect [8, 411. An increase occurred in glucagon but this hormone certainly does not stimulate muscle protein synthesis at the concentrations found and may decrease it at pathophysiological-concentrations [42] .
It remains possible that growth hormone itself induced the reported changes as this hormone is shown to have an acute, direct insulin-like effect on rat muscle protein synthesis in vitro [43] . Insulin-like growth factors, expressed by messenger ribonucleic acids in most human foetal tissues, including muscle [44] , may have exerted a paracrine influence to modulate increases in protein synthesis in response to amino acid provision, but in identical studies we were unable to measure any change in plasma insulin-like growth factor 1 concentration in response to an identical infusion of amino acids [basal 790 (SD 240) versus amino acids 790 (SD 220) units/l, n = 51. Since the anabolic effect of the exogenous amino acids on muscle cannot be firmly identified with changes in availability of insulin, glucagon (or cortisol, glucose and ketone bodies, none of which changed in concentration), we are therefore forced to the conclusion that either the simple increase in intramuscular concentration of amino acids or an increase in some other unknown anabolic factor caused the observed increase in muscle protein synthesis. The present results strongly suggest that a major component in the twofold increase seen in muscle protein synthesis in going from the postabsorptive to the fed state [l, 21 is simply due to an increased availability of amino acids.
The [45] . At present the relative synthetic rates for human type 1 and type 2 muscle fibres are not known, but it is known that in animals muscles with predominantly type 1 fibre composition turn over faster than those with predominantly type 2 [36, 42, 46] .
The absolute values, and the changes that occurred between the postabsorptive and amino acid supplemented states in the plasma fluxes of leucine and KIC, and the rates of oxidation of leucine, are in accord with these expected from previous work [lo, 111. The most important feature of the results for the present discussion is the net anabolic effect of exogenous amino acids due to an increase in non-oxidative leucine disappearance (wholebody protein synthesis) and a reduction in the appearance of leucine from protein breakdown.
Given the fact that skeletal muscle contributes about 50% of lean body mass [47] , it is possible to calculate (assuming that muscle contains 180 mg of protein/g, protein contains 8% leucine and all skeletal muscle is similar to anterior tibialis) the contribution of muscle to whole-body protein synthesis (non-oxidized leucine disappearance): it would be 24 pmol h-' kg-' in the postabsorptive state and 33 pmol h-' kg-' during exogenous amino acid infusion. These estimates would be reduced by 16% if skeletal muscle turnover generally reflected that of quadriceps. Such calculations suggest that in the postabsorptive state skeletal muscle may account for between 20 and 24% of whole-body protein synthesis. The relative change, on addition of exogenous amino acids, was twice as great for anterior tibialis than for the whole-body protein mass, suggesting that muscle increased its contribution; indeed calculations show that the proportion of whole-body protein synthesis due to muscle rose to between 23 and 28%. This is less than the contribution previously calculated [ 11 because of the revised, lower values now routinely obtained for skeletal muscle protein synthesis [2, 5] .
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